Hologic, Inc. HOLX
76.01 USD 0.00 (+0.00%)
At closeApr 7, 2026, 4:00 PM EDT
76.04 +0.03 +0.04%
After hours · Apr 7, 4:00 PM ET
76.01 Day range 76.01
52-week range unavailable
- YTD
- +2.04%
- 1 year
- +24.06%
Analyst view
Consensus: hold
Hold
Price target (mean) 76.67 +0.9% upside
Now 76.01
- Target (low)
- 76.00
- Target (mean)
- 76.67
- Target (high)
- 78.00
Ratings (0m) 15 0 buy · 15 hold · 0 sell
- Strong buy0
- Buy0
- Hold15
- Sell0
- Strong sell0
Recommendation trend
- This month 15
- 1 month ago 15
- 2 months ago 16
- 3 months ago 17
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.07 | 1.01 – 1.14 | 1.03 | +3.8% | 1.03B | +2.5% | 12 |
| Next quarter | 1.12 | 1.09 – 1.18 | 1.08 | +4.0% | 1.05B | +2.9% | 10 |
| Current year | 4.46 | 4.35 – 4.64 | 4.26 | +4.6% | 4.24B | +3.3% | 15 |
| Next year | 3.78 | 3.05 – 4.39 | 3.27 | +15.4% | 4.46B | +5.3% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 12, 2026 | Argus Research | Downgrade | Buy | Hold |
| Jan 5, 2026 | Evercore ISI Group | Downgrade | Outperform | In-Line |
| Nov 11, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Oct 23, 2025 | Mizuho | Downgrade | Outperform | Neutral |
| Oct 22, 2025 | Raymond James | Downgrade | Outperform | Market Perform |
| Oct 22, 2025 | Stephens & Co. | Downgrade | Overweight | Equal-Weight |
| Oct 22, 2025 | JP Morgan | Downgrade | Overweight | Neutral |
| Oct 21, 2025 | Leerink Partners | Maintained | Market Perform | Market Perform |
| Oct 21, 2025 | BTIG | Reiterated | Neutral | Neutral |
| Oct 21, 2025 | Needham | Reiterated | Hold | Hold |
| Oct 7, 2025 | Evercore ISI Group | Upgrade | In-Line | Outperform |
| Sep 19, 2025 | Argus Research | Maintained | Buy | Buy |
| Sep 18, 2025 | Stephens & Co. | Reiterated | Overweight | Overweight |
| Aug 6, 2025 | RBC Capital | Upgrade | Sector Perform | Outperform |
| Jul 31, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2025 | UBS | Maintained | Neutral | Neutral |
| Jul 16, 2025 | Mizuho | Maintained | Outperform | Outperform |
| Jul 9, 2025 | Citigroup | Upgrade | Neutral | Buy |
| Jul 8, 2025 | Evercore ISI Group | Maintained | In-Line | In-Line |
| May 28, 2025 | Needham | Reiterated | Hold | Hold |
| May 13, 2025 | Stephens & Co. | Maintained | Overweight | Overweight |
| May 5, 2025 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| May 2, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| May 2, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| May 2, 2025 | Evercore ISI Group | Maintained | In-Line | In-Line |
| May 2, 2025 | Needham | Reiterated | Hold | Hold |
| Apr 8, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Mar 4, 2025 | Citigroup | Maintained | Neutral | Neutral |
| Feb 6, 2025 | Raymond James | Reiterated | Outperform | Outperform |
| Feb 6, 2025 | RBC Capital | Maintained | Sector Perform | Sector Perform |